JNJ

240.21

+1.13%↑

UNH

274.43

-1.1%↓

TMO

544.51

+0.02%↑

ABT

112.63

+1.52%↑

ISRG

496.26

+0.87%↑

JNJ

240.21

+1.13%↑

UNH

274.43

-1.1%↓

TMO

544.51

+0.02%↑

ABT

112.63

+1.52%↑

ISRG

496.26

+0.87%↑

JNJ

240.21

+1.13%↑

UNH

274.43

-1.1%↓

TMO

544.51

+0.02%↑

ABT

112.63

+1.52%↑

ISRG

496.26

+0.87%↑

JNJ

240.21

+1.13%↑

UNH

274.43

-1.1%↓

TMO

544.51

+0.02%↑

ABT

112.63

+1.52%↑

ISRG

496.26

+0.87%↑

JNJ

240.21

+1.13%↑

UNH

274.43

-1.1%↓

TMO

544.51

+0.02%↑

ABT

112.63

+1.52%↑

ISRG

496.26

+0.87%↑

Search

McKesson Corp

Abierto

SectorSalud

936.64 -2.32

Resumen

Variación precio

24h

Actual

Mínimo

929.77

Máximo

964.74

Métricas clave

By Trading Economics

Ingresos

426M

1.2B

Ventas

5.3B

103B

P/B

Media del Sector

26.453

84.243

Rentabilidad por dividendo

0.35

Margen de beneficio

1.173

Empleados

43,000

EBITDA

212M

1.5B

Recomendaciones

By TipRanks

Recomendaciones

Compra Fuerte

Estimación a 12 meses

-0.16% downside

Dividendos

By Dow Jones

Rentabilidad por dividendo

Media del Sector

0.35%

2.28%

Próximas Ganancias

7 may 2026

Fecha Próximo Dividendo

1 abr 2026

Próxima Fecha de Ex Dividendo

2 mar 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización de Mercado

3.3B

105B

Apertura anterior

938.96

Cierre anterior

936.64

Noticias sobre sentimiento de mercado

By Acuity

36%

64%

99 / 352 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Strong Bearish Evidence

McKesson Corp Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

9 feb 2026, 17:25 UTC

Adquisiciones, fusiones, absorciones

Eli Lilly to Buy Biotech Orna Therapeutics for Up to $2.4 Billion -- Update

9 feb 2026, 23:46 UTC

Charlas de Mercado

Nikkei May Rise on Hopes for Domestic Policy Measures -- Market Talk

9 feb 2026, 23:43 UTC

Charlas de Mercado

Gold Falls on Possible Technical Correction -- Market Talk

9 feb 2026, 23:14 UTC

Charlas de Mercado

WiseTech's Bull Reckons AI-Driven Selloff Is Overdone -- Market Talk

9 feb 2026, 22:29 UTC

Charlas de Mercado

Australian Coking Coal Price Seen Falling Once Supply Disruptions Ease -- Market Talk

9 feb 2026, 22:19 UTC

Charlas de Mercado

Pro Medicus's Business Case Made More Compelling by AI Adoption -- Market Talk

9 feb 2026, 22:08 UTC

Charlas de Mercado

Minerals 260 Bull Bets on Production Scale, Takeover Appeal -- Market Talk

9 feb 2026, 22:01 UTC

Ganancias

Friedman Industries Sees 4Q Sales Volume to Generally Consistent With 3Q, With Sequential Improvement in Sales Margins

9 feb 2026, 21:59 UTC

Ganancias

Friedman Industries: Hedging Activities Continued to Perform as Anticipated by Mitigating Impact of Commodity Price Volatility

9 feb 2026, 21:59 UTC

Ganancias

Friedman Industries: Average Selling Prices Began to Improve as Quarter Progressed

9 feb 2026, 21:58 UTC

Ganancias

Friedman Industries 3Q Sales $168M >FRD

9 feb 2026, 21:50 UTC

Charlas de Mercado
Adquisiciones, fusiones, absorciones

Financial Services Roundup: Market Talk

9 feb 2026, 21:50 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

9 feb 2026, 21:48 UTC

Ganancias

Friedman Industries 3Q EPS 43c >FRD

9 feb 2026, 21:17 UTC

Ganancias

Kyndryl Stock Drops 55%. It's So Much Worse Than an Earnings Miss. -- Barrons.com

9 feb 2026, 21:13 UTC

Charlas de Mercado

U.S. Ethanol Crush Margins Near Break-Even -- Market Talk

9 feb 2026, 21:04 UTC

Ganancias

Retail Sales Data Should Confirm a Robust Holiday Season -- Barrons.com

9 feb 2026, 20:30 UTC

Charlas de Mercado

Oil Futures Gain As U.S.-Iran Risk Premium Holds -- Market Talk

9 feb 2026, 20:02 UTC

Charlas de Mercado

U.S. Natural Gas Falls on Warmer Weather Outlook -- Market Talk

9 feb 2026, 19:42 UTC

Charlas de Mercado

Japan's Yield Curve Expected to Flatten -- Market Talk

9 feb 2026, 19:31 UTC

Charlas de Mercado

Nike Seen Regaining Relevance With Consumers -- Market Talk

9 feb 2026, 19:27 UTC

Charlas de Mercado

Gold Climbs Back Over $5,000/oz -- Market Talk

9 feb 2026, 19:05 UTC

Charlas de Mercado

Nike Returns to List of Hottest Brands -- Market Talk

9 feb 2026, 18:19 UTC

Charlas de Mercado

Lower Dollar Doesn't Translate to Boost in Grains -- Market Talk

9 feb 2026, 17:41 UTC

Ganancias
Adquisiciones, fusiones, absorciones

These Stocks Are Today's Movers: Kyndryl, Hims & Hers, Novo Nordisk, AppLovin, Monday.com, Valaris, and More -- Barrons.com

9 feb 2026, 17:31 UTC

Ganancias
Adquisiciones, fusiones, absorciones

These Stocks Are Today's Movers: Kyndryl, Hims & Hers, Novo Nordisk, Monday.com, Valaris, Cleveland-Cliffs, and More -- Barrons.com

9 feb 2026, 17:20 UTC

Charlas de Mercado
Adquisiciones, fusiones, absorciones

Financial Services Roundup: Market Talk

9 feb 2026, 17:20 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

9 feb 2026, 17:17 UTC

Charlas de Mercado

Century Aluminum Announces Next Steps of Okla. Project -- Market Talk

9 feb 2026, 17:16 UTC

Ganancias

Kyndryl Stock Drops 56%. It's So Much Worse Than an Earnings Miss. -- Barrons.com

Comparación entre iguales

Cambio de precio

McKesson Corp Esperado

Precio Objetivo

By TipRanks

-0.16% caída

Estimación a 12 meses

Media 960.8 USD  -0.16%

Máximo 1,012 USD

Mínimo 885 USD

De acuerdo con 10 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para McKesson Corp Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

10 ratings

8

Comprar

2

Mantener

0

Vender

Puntuación técnica

By Trading Central

681.92 / 707.28Soporte y Resistencia

Corto Plazo

Strong Bearish Evidence

Medio plazo

No Evidence

Largo Plazo

No Evidence

Sentimiento

By Acuity

99 / 352 Clasificación en Salud

Noticias sobre sentimiento de mercado

Coyuntura alcista

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de McKesson Corp

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners, and patients to address medication challenges for patients by working across healthcare; connects patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver innovative solutions to help people get the medicine needed to live healthier lives; and provides prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services. The Medical-Surgical Solutions segment offers medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. The International segment provides distribution and services to wholesale, institutional, and retail customers in Europe and Canada. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
help-icon Live chat